Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Question on valuing shares from time of spinoff

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Question on valuing shares from time of spinoff

bfw

Jul 18, 2018 01:19PM

Re: Question on valuing shares from time of spinoff

narmac

Jul 18, 2018 03:17PM

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Question on valuing shares from time of spinoff

in response to

Question on valuing shares from time of spinoff

bfw

posted on Jul 18, 2018 03:40PM

I think Zenith will have to provide a statement on the initial share cost, as RVX did for RVX. I don't think the brokerage numbers are worth anything. Mine shows a cost of 14¢ CAD and a current value of 50¢ USD.

4 Recommendations

Re: Question on valuing shares from time of spinoff

chicagoest

Jul 18, 2018 04:13PM

Re: Question on valuing shares from time of spinoff

tada

Jul 18, 2018 04:15PM

Re: Question on valuing shares from time of spinoff

bfw

Jul 18, 2018 04:28PM

Re: Question on valuing shares from time of spinoff

tada